Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Transitioning young patients from pediatric to adult rheumatology care is a high-risk period — and nearly half never return after their first adult visit. Insurance gaps, medication adherence issues, and emotional challenges all converge at once. Experts say adult rheumatologists need to take a more active, welcoming role to keep these patients on track.
For young patients with rheumatic diseases diagnosed in childhood, moving from pediatric to adult care isn't just a logistical shift — it's an emotionally charged and medically risky transition. Speaking at the Congress of Clinical Rheumatology West, Dr. John M. Bridges of the University of Alabama at Birmingham called this period a "scary time," noting that patients face a convergence of insurance changes, geographic moves, and adherence challenges all at once.
The stakes are high: roughly 50% of pediatric rheumatology patients are lost to follow-up after their very first visit to an adult provider. Bridges emphasized that adult rheumatologists must go beyond simply accepting a new patient — they need to actively engage, understand the patient's full history, and ideally communicate directly with the outgoing pediatric rheumatologist.
Key Takeaways:
Why it matters: With chronic pediatric rheumatic diseases like JIA and childhood-onset lupus requiring lifelong management, losing patients during this transition can lead to disease flares, organ damage, and long-term disability — making a smooth handoff a genuine clinical priority.